FTH Surges 69.8% on EPS Revision; LILA, CRMT Also Jump
Faeth Therapeutics (FTH) led with a 69.8% gain after analysts revised its forward EPS growth estimate to 93.7% on June 16. Liberty Latin America (LILA) jumped 45.8% on a 131.8 percentage point upward revision, while CRMT gained 62.0% on a 101.7% EPS growth estimate. All moves occurred without direct earnings news, highlighting the market's confidence in the revised outlooks.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| FTH | Healthcare | 2026-06-16 | N/A | +69.8% |
| CRMT | Consumer Cyclical | 2026-06-16 | N/A | +62.0% |
| LILA | Communication Services | 2026-06-18 | +131.8pp | +45.8% |
| LILAK | Communication Services | 2026-06-18 | +1799.9pp | +44.3% |
| HELP | Healthcare | 2026-06-21 | N/A | +28.9% |
Why did FTH stock jump in June 2026?
FTH jumped 69.8% (from $14.53 to $24.67) after analysts revised its forward EPS growth estimate to 93.7% on June 16.
The healthcare sector has seen renewed interest in small-cap biotechs, and Faeth's strong revision signaled improving profitability prospects. The screener captured this estimate change early, and the subsequent price rally confirmed market validation. No additional news emerged during the window, reinforcing that the revision alone drove the move.
FTH EPS revision history → · Screener snapshot from 2026-06-16 →
FAQ: FTH
Why did FTH stock jump in June 2026?
FTH jumped 69.8% on June 16 after analysts raised its forward EPS growth estimate to 93.7%, signaling a sharp profit recovery.
Is FTH a buy after the rally?
The 69.8% rally reflects the market pricing in the upward revision. Investors should assess whether the 93.7% EPS growth estimate is sustainable before buying.
What is FTH's EPS growth estimate?
FTH's current forward EPS growth estimate is 93.7% for next year, as revised on June 16.
Why did CRMT stock jump in June 2026?
CRMT jumped 62.0% (from $2.34 to $3.79) after analysts raised its forward EPS growth estimate to 101.7% on June 16.
The consumer cyclical sector saw a broad uptick in expectations as used car demand stabilized, and America's Car Mart's heavy revision stood out. The screener flagged the estimate change early, and the subsequent price surge confirmed investor optimism despite no company-specific news.
CRMT EPS revision history → · Screener snapshot from 2026-06-16 →
FAQ: CRMT
Why did CRMT stock jump in June 2026?
CRMT jumped 62.0% on June 16 after its forward EPS growth estimate was revised to 101.7%, signaling a strong earnings turnaround.
What caused CRMT's surge?
The surge was caused by an upward EPS revision to 101.7% growth, catching investor attention in a recovering consumer cyclical sector.
What is CRMT's EPS growth estimate?
CRMT's forward EPS growth estimate is currently 101.7% for next year, as revised on June 16.
Why did LILA stock jump in June 2026?
LILA jumped 45.8% (from $4.80 to $7.00) after analysts dramatically raised its EPS growth estimate from 208.4% to 340.3% on June 18.
The communication services sector benefited from improving Latin American market conditions, and Liberty Latin America's massive revision highlighted a potential inflection in profitability. The screener detected the revision early, and the stock's rally validated the upgraded outlook, even without accompanying news.
LILA EPS revision history → · Screener snapshot from 2026-06-18 →
FAQ: LILA
Why did LILA stock jump in June 2026?
LILA jumped 45.8% on June 18 after its EPS growth estimate was revised from 208.4% to 340.3%, a massive 131.8 percentage point boost.
Is LILA a buy after the rally?
The 45.8% rally reflects the upward revision, but investors should consider the sustainability of 340.3% EPS growth and Latin America risks.
What is LILA's EPS growth estimate?
LILA's current forward EPS growth estimate is 340.3%, revised up from 208.4% on June 18.
Why did LILAK stock jump in June 2026?
LILAK jumped 44.3% (from $4.79 to $6.91) after analysts revised its EPS growth estimate from 413.6% to 2213.6% on June 18, a 1799.9 percentage point jump.
As another share class of Liberty Latin America, it moved in tandem with LILA, reflecting the same underlying sector optimism in communication services. The screener flagged this extraordinary revision, and the market responded with a strong price confirmation despite no fresh news.
LILAK EPS revision history → · Screener snapshot from 2026-06-18 →
FAQ: LILAK
Why did LILAK stock jump in June 2026?
LILAK jumped 44.3% on June 18 after its EPS growth estimate was revised from 413.6% to 2213.6%, a 1,799.9 percentage point increase.
What caused LILAK's surge?
A massive upward EPS revision of 1,799.9 percentage points drove the surge, signaling a dramatic earnings rebound expected by analysts.
What is LILAK's EPS growth estimate?
LILAK's forward EPS growth estimate is currently 2213.6%, revised up from 413.6% on June 18.
Why did HELP stock jump in June 2026?
HELP jumped 28.9% (from $4.67 to $6.02) after analysts raised its forward EPS growth estimate to 27.7% on June 21.
The healthcare sector has been supported by steady demand for specialty pharmaceuticals, and Helus Pharma's revision suggested improving margins. The screener detected the estimate change days before the price peak, and the subsequent rally confirmed market acceptance of the revised outlook without any additional news catalysts.
HELP EPS revision history → · Screener snapshot from 2026-06-21 →
FAQ: HELP
Why did HELP stock jump in June 2026?
HELP jumped 28.9% on June 21 after its forward EPS growth estimate was raised to 27.7%, indicating stronger earnings expectations.
Is HELP a buy after the rally?
The 28.9% gain followed the revision, but investors should evaluate whether the 27.7% EPS growth target is achievable given market conditions.
What is HELP's EPS growth estimate?
HELP's current forward EPS growth estimate is 27.7%, as revised on June 21.
Today's top gainers all responded to upward EPS revisions without accompanying news, underscoring the market's sensitivity to forward earnings expectations. The concentration in healthcare and communication services suggests sector-specific optimism, with investors betting on sharp profit turnarounds.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →